Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of SU011248 in combination with docetaxel in patients with advanced solid tumors and non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• SU011248

Snippet

Sponsor: Pfizer | Conditions: Advanced Solid Tumors, Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED